Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders.

Trace metals such as iron, copper, zinc, manganese, and cobalt are essential cofactors for many cellular enzymes. Extensive research on iron, the most abundant transition metal in biology, has contributed to an increased understanding of the molecular machinery involved in maintaining its homeostasis in mammalian peripheral tissues. However, the cellular and intercellular iron transport mechanisms in the central nervous system (CNS) are still poorly understood. Accumulating evidence suggests that impaired iron metabolism is an initial cause of neurodegeneration, and several common genetic and sporadic neurodegenerative disorders have been proposed to be associated with dysregulated CNS iron homeostasis. This review aims to provide a summary of the molecular mechanisms of brain iron transport. Our discussion is focused on iron transport across endothelial cells of the blood-brain barrier and within the neuro- and glial-vascular units of the brain, with the aim of revealing novel therapeutic targets for neurodegenerative and CNS disorders.

[1]  S. Powers,et al.  Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain , 1999, Journal of neurochemistry.

[2]  C. Ponting,et al.  Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. , 2003, Biochimica et biophysica acta.

[3]  E. Morgan,et al.  Brain capillary endothelial cells mediate iron transport into the brain by segregating iron from transferrin without the involvement of divalent metal transporter 1 , 2006, Journal of neurochemistry.

[4]  J. Connor,et al.  Mechanisms and regulation of transferrin and iron transport in a model blood–brain barrier system , 2003, Neuroscience.

[5]  B. Todorich,et al.  Tim‐2 is the receptor for H‐ferritin on oligodendrocytes , 2008, Journal of neurochemistry.

[6]  M. Hentze,et al.  Balancing Acts Molecular Control of Mammalian Iron Metabolism , 2004, Cell.

[7]  B. N. Patel,et al.  A Novel Glycosylphosphatidylinositol-anchored Form of Ceruloplasmin Is Expressed by Mammalian Astrocytes* , 1997, The Journal of Biological Chemistry.

[8]  Daniela Berg,et al.  Iron metabolism in Parkinsonian syndromes , 2006, Movement disorders : official journal of the Movement Disorder Society.

[9]  D. Richardson,et al.  The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. , 1997, Biochimica et biophysica acta.

[10]  J. Andersen,et al.  Iron dysregulation and neurodegeneration: the molecular connection. , 2006, Molecular interventions.

[11]  Z. Qian,et al.  Transferrin receptors on the plasma membrane of cultured rat astrocytes , 1999, Experimental Brain Research.

[12]  B. Todorich,et al.  Oligodendrocytes and myelination: The role of iron , 2009, Glia.

[13]  Shawn K. Westaway,et al.  A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome , 2001, Nature Genetics.

[14]  Charles Duyckaerts,et al.  Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease , 2008, Proceedings of the National Academy of Sciences.

[15]  E. Morgan,et al.  Transferrin and Iron Uptake by the Brain: Effects of Altered Iron Status , 1991, Journal of neurochemistry.

[16]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.

[17]  W. Jefferies,et al.  Transferrin receptor on endothelium of brain capillaries , 1984, Nature.

[18]  K. Arima,et al.  Astrocytic Deformity and Globular Structures Are Characteristic of the Brains of Patients with Aceruloplasminemia , 2002, Journal of neuropathology and experimental neurology.

[19]  Subramanian Rajagopalan,et al.  Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo A Novel Therapy for Parkinson's Disease , 2003, Neuron.

[20]  N. Andrews,et al.  Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. , 2005, The Journal of clinical investigation.

[21]  N. Andrews,et al.  ASH 50th Anniversary Reviews (34 articles) , 2022 .

[22]  Sheryl E. Koch,et al.  L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy , 2003, Nature Medicine.

[23]  Z. Sheng,et al.  Expression of the iron transporter ferroportin in synaptic vesicles and the blood–brain barrier , 2004, Brain Research.

[24]  M. Fleming,et al.  The Steap proteins are metalloreductases. , 2006, Blood.

[25]  E. Ling,et al.  Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. , 1994, Journal of anatomy.

[26]  N. Andrews,et al.  Iron homeostasis. , 2007, Annual review of physiology.

[27]  N. Andrews,et al.  Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice , 2007, Nature Genetics.

[28]  K. Iwasaki,et al.  Intracellular iron transport and storage: from molecular mechanisms to health implications. , 2008, Antioxidants & redox signaling.

[29]  D. McLachlan,et al.  Intramuscular desferrioxamine in patients with Alzheimer's disease , 1991, The Lancet.

[30]  A. Shevchenko,et al.  Huntingtin–HAP40 complex is a novel Rab5 effector that regulates early endosome motility and is up-regulated in Huntington's disease , 2006, The Journal of cell biology.

[31]  L. Rashed,et al.  The role of iron dysregulation in the pathogenesis of multiple sclerosis: an Egyptian study , 2008, Multiple sclerosis.

[32]  W. Pardridge,et al.  Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood–brain barrier delivery in the mouse , 2009, Biotechnology and bioengineering.

[33]  R. Richards,et al.  Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. , 2007, Human molecular genetics.

[34]  A. Donovan,et al.  The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. , 2005, Cell metabolism.

[35]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[36]  J. Eaton,et al.  Prevention of oxidant-induced cell death by lysosomotropic iron chelators. , 2003, Free radical biology & medicine.

[37]  S. David,et al.  Phospholipase A2 plays an important role in myelin breakdown and phagocytosis during wallerian degeneration , 2003, Molecular and Cellular Neuroscience.

[38]  J. Connor,et al.  Developmental changes in the expression of iron regulatory proteins and iron transport proteins in the perinatal rat brain , 2002, Journal of neuroscience research.

[39]  L. Fenart,et al.  Receptor-mediated Transcytosis of Lactoferrin through the Blood-Brain Barrier* , 1999, The Journal of Biological Chemistry.

[40]  A. Brownlie,et al.  Mitoferrin is essential for erythroid iron assimilation , 2006, Nature.

[41]  Michela Matteoli,et al.  Vesicular transmitter release from astrocytes , 2006, Glia.

[42]  E. Morgan,et al.  The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review , 2004, Annals of the New York Academy of Sciences.

[43]  R. Schiffmann,et al.  Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel. , 2000, Human molecular genetics.

[44]  A. Holmgren,et al.  Glutaredoxin systems. , 2008, Biochimica et biophysica acta.

[45]  Ashley I Bush,et al.  Metals in Alzheimer's and Parkinson's diseases. , 2008, Current opinion in chemical biology.

[46]  J. Connor,et al.  Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat , 2001, Journal of neuroscience research.

[47]  Xian-Ping Dong,et al.  The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel , 2008, Nature.

[48]  Mark A. Smith,et al.  Nanoparticle–chelator conjugates as inhibitors of amyloid-β aggregation and neurotoxicity: A novel therapeutic approach for Alzheimer disease , 2009, Neuroscience Letters.

[49]  M. Garrick,et al.  Cellular iron transport. , 2009, Biochimica et biophysica acta.

[50]  T. Rouault.  The role of iron regulatory proteins in mammalian iron homeostasis and disease , 2006, Nature chemical biology.

[51]  J. Gitlin,et al.  Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[52]  H. Schipper.  Brain iron deposition and the free radical-mitochondrial theory of ageing , 2004, Ageing Research Reviews.

[53]  A. Grover,et al.  Role of transient receptor potential canonical 6 (TRPC6) in non-transferrin-bound iron uptake in neuronal phenotype PC12 cells. , 2004, The Biochemical journal.

[54]  S. David,et al.  Glycosylphosphatidylinositol-anchored Ceruloplasmin Is Required for Iron Efflux from Cells in the Central Nervous System* , 2003, Journal of Biological Chemistry.

[55]  J. Balsinde,et al.  Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. , 2005, Cellular signalling.

[56]  R. Cousins,et al.  Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells , 2006, Proceedings of the National Academy of Sciences.

[57]  J. J. Sharp,et al.  Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells , 2005, Nature Genetics.

[58]  R J Simpson,et al.  An Iron-Regulated Ferric Reductase Associated with the Absorption of Dietary Iron , 2001, Science.

[59]  Gregory J. Anderson,et al.  Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse , 1999, Nature Genetics.

[60]  J. Connor,et al.  Ferritin: a novel mechanism for delivery of iron to the brain and other organs. , 2007, American journal of physiology. Cell physiology.

[61]  U. Brunk,et al.  Lysosomes in iron metabolism, ageing and apoptosis , 2008, Histochemistry and Cell Biology.

[62]  C. Morris,et al.  Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease , 2001, Nature Genetics.

[63]  Timothy Schallert,et al.  Iron is essential for neuron development and memory function in mouse hippocampus. , 2009, The Journal of nutrition.

[64]  E. Morgan,et al.  Evidence for low molecular weight, non‐transferrin‐bound iron in rat brain and cerebrospinal fluid , 1998, Journal of neuroscience research.

[65]  R. Puertollano,et al.  TRPMLs: in sickness and in health. , 2009, American journal of physiology. Renal physiology.

[66]  A. Shevchenko,et al.  Huntingtin – HAP 40 complex is a novel Rab 5 effector that regulates early endosome motility and is up-regulated in Huntington ’ s disease , 2022 .

[67]  Colin A. Johnson,et al.  PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron , 2006, Nature Genetics.

[68]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[69]  M. L. Ujwal,et al.  Divalent metal-ion transporter DMT1 mediates both H+ -coupled Fe2+ transport and uncoupled fluxes , 2005, Pflügers Archiv.

[70]  Marino Zerial,et al.  Rab proteins as membrane organizers , 2001, Nature Reviews Molecular Cell Biology.

[71]  M. Georgieff,et al.  Iron deficiency and brain development. , 2006, Seminars in pediatric neurology.

[72]  Stephan Nussberger,et al.  Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.

[73]  S. Grinstein,et al.  Natural Resistance to Intracellular Infections , 2000, The Journal of experimental medicine.

[74]  F. Petrat,et al.  Determination of the chelatable iron pool of single intact cells by laser scanning microscopy. , 2000, Archives of biochemistry and biophysics.

[75]  E. Pollitt,et al.  Early iron deficiency anemia and later mental retardation. , 1999, The American journal of clinical nutrition.

[76]  G. Oudit,et al.  Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload. , 1999, Circulation research.

[77]  P. Gros,et al.  Distinct targeting and recycling properties of two isoforms of the iron transporter DMT1 (NRAMP2, Slc11A2). , 2006, Biochemistry.

[78]  Ya Ke,et al.  Brain iron metabolism: Neurobiology and neurochemistry , 2007, Progress in Neurobiology.

[79]  M. Smith,et al.  Redox metals and neurodegenerative disease. , 1999, Current opinion in chemical biology.

[80]  E. Caler,et al.  Plasma Membrane Repair Is Mediated by Ca2+-Regulated Exocytosis of Lysosomes , 2001, Cell.

[81]  H. Schipper,et al.  Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides. , 2000, Cellular and molecular biology.

[82]  J. Duncan,et al.  Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. , 2005, Human molecular genetics.

[83]  Wei Feng,et al.  Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. , 2009, International journal of pharmaceutics.

[84]  Simone Sanna-Cherchi,et al.  Scara5 is a ferritin receptor mediating non-transferrin iron delivery. , 2009, Developmental cell.

[85]  I. Kjellmer,et al.  Non-Protein-Bound Iron in Brain Interstitium of Newborn Pigs after Hypoxia , 2005, Developmental Neuroscience.

[86]  S. Robinson,et al.  The Pivotal Role of Astrocytes in the Metabolism of Iron in the Brain , 2007, Neurochemical Research.

[87]  W. Jefferies,et al.  Coincident expression and distribution of melanotransferrin and transferrin receptor in human brain capillary endothelium , 1996, Brain Research.

[88]  M. Bradbury.  Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System , 1997, Journal of neurochemistry.

[89]  J. Chen,et al.  The oxidative neurotoxicity of clioquinol , 2005, Neuropharmacology.

[90]  R. Keep,et al.  Brain Injury After Intracerebral Hemorrhage: The Role of Thrombin and Iron , 2007, Stroke.

[91]  Roberto Cappai,et al.  The redox chemistry of the Alzheimer's disease amyloid β peptide , 2007 .

[92]  Kazuhiro Iwai,et al.  Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice , 2001, Nature Genetics.

[93]  E. Morgan,et al.  Iron trafficking inside the brain , 2007, Journal of neurochemistry.

[94]  M. Linder,et al.  Release of iron from ferritin requires lysosomal activity. , 2006, American journal of physiology. Cell physiology.

[95]  J. Connor,et al.  Is ferroportin–hepcidin signaling altered in restless legs syndrome? , 2006, Journal of the Neurological Sciences.

[96]  A. Brownlie,et al.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.

[97]  J. Connor,et al.  Brain iron uptake in hypotransferrinemic mice: Influence of systemic iron status , 2005, Journal of neuroscience research.

[98]  James R. Connor,et al.  Brain iron uptake and homeostatic mechanisms: An overview , 2003, Biometals.